The DOI matches its Crossref record; 61 of the 61 references it cites were found in a registry or an index.
Cannabinoid Ligands Targeting TRP Channels
Open accessAbstract
Transient receptor potential (TRP) channels are a group of membrane proteins involved in the transduction of a plethora of chemical and physical stimuli. These channels modulate ion entry, mediating a variety of neural signaling processes implicated in the sensation of temperature, pressure, and pH, as well as smell, taste, vision, and pain perception. Many diseases involve TRP channel dysfunction, including neuropathic pain, inflammation, and respiratory disorders, and in the venture to find new treatments for these disorders, it was discovered that cannabinoids can modulate a certain subset of TRP channels. The vanilloid (TRPV), ankyrin (TRPA), and melastatin (TRPM) subfamilies were all found to contain channels that can be modulated by several endogenous, phytogenic, and synthetic cannabinoids. To date, six types of TRP channels of the aforementioned three subfamilies have been reported to mediate cannabinoid activity: TRPV1, TRPV2, TRPV3, TRPV4, TRPA1, and TRPM8. The increasing data regarding cannabinoid interactions with these receptors has prompted some researchers to consider these TRP channels as the “ionotropic cannabinoid receptors”. Although CB1 and CB2 are considered to be the canonical cannabinoid receptors, there is significant overlap between cannabinoids and ligands of TRP receptors. The first endogenous agonist of TRPV1 to be discovered was the endocannabinoid, anandamide (AEA). Similarly, N-arachidonyl dopamine (NADA) and anandamide were the first endogenous TRPM8 antagonists discovered. Additionally, Δ9-tetrahydrocannabinol (∆9-THC), the most abundant psychotropic compound in cannabis, acts most potently at TRPV2, moderately modulates TRPV3, TRPV4, TRPA1, and TRPM8, though is not reported to modulate TRPV1. Moreover, TRP receptors may modulate effects of synthetic cannabinoids used in research. One common research tool is WIN55,212-2, a CB1 agonist that also exerts analgesic effects by desensitizing TRPA1 and TRPV1. In this review, we aim to provide an overview and classification of the cannabinoid ligands that have been reported to modulate TRP channels and their therapeutic potential.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Vanilloid receptors on sensory nerves mediate the vasodilator action of anandamide
Zygmunt, P. M., Petersson, J., Andersson, D. A., Chuang, H.-H., Sørgård, M., Di Marzo, V., Julius, D., & Högestätt, E. D. (1999) · Nature · doi:10.1038/22761 · Cited by 2,142
The induction of pain: an integrative review
Millan, M. J. (1999) · Progress in Neurobiology · doi:10.1016/s0301-0082(98)00048-3 · Cited by 1,774
Bisogno, T., Hanuš, L., De Petrocellis, L., Tchilibon, S., Ponde, D. E., Brandi, I., Moriello, A. S., Davis, J. B., Mechoulam, R., & Di Marzo, V. (2001) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0704327 · Cited by 1,311
Cannabidiol is a negative allosteric modulator of the cannabinoid CB 1 receptor
Laprairie, R. B., Bagher, A. M., Kelly, M. E. M., & Denovan‐Wright, E. M. (2015) · British Journal of Pharmacology · doi:10.1111/bph.13250 · Cited by 1,039
Anandamide and arachidonic acid use epoxyeicosatrienoic acids to activate TRPV4 channels
Watanabe, H., Vriens, J., Prenen, J., Droogmans, G., Voets, T., & Nilius, B. (2003) · Nature · doi:10.1038/nature01807 · Cited by 1,027
OTRPC4, a nonselective cation channel that confers sensitivity to extracellular osmolarity
Strotmann, R., Harteneck, C., Nunnenmacher, K., Schultz, G., & Plant, T. D. (2000) · Nature Cell Biology · doi:10.1038/35036318 · Cited by 1,023
Huang, S. M., Bisogno, T., Trevisani, M., Al-Hayani, A., De Petrocellis, L., Fezza, F., Tognetto, M., Petros, T. J., Krey, J. F., Chu, C. J., et al. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.122196999 · Cited by 964
De Petrocellis, L., Ligresti, A., Moriello, A. S., Allarà, M., Bisogno, T., Petrosino, S., Stott, C. G., & Di Marzo, V. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.01166.x · Cited by 946
The transient receptor potential family of ion channels
Nilius, B., & Owsianik, G. (2011) · Genome Biology · doi:10.1186/gb-2011-12-3-218 · Cited by 919
Pedersen, S. F., Owsianik, G., & Nilius, B. (2005) · Cell Calcium · doi:10.1016/j.ceca.2005.06.028 · Cited by 774
Structure of the TRPA1 ion channel suggests regulatory mechanisms
Paulsen, C. E., Armache, J.-P., Gao, Y., Cheng, Y., & Julius, D. (2015) · Nature · doi:10.1038/nature14367 · Cited by 660
Ligresti, A., Moriello, A. S., Starowicz, K., Matias, I., Pisanti, S., De Petrocellis, L., Laezza, C., Portella, G., Bifulco, M., & Di Marzo, V. (2006) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.106.105247 · Cited by 568
Nilius, B., & Szallasi, A. (2014) · Pharmacological Reviews · doi:10.1124/pr.113.008268 · Cited by 506
Cristino, L., de Petrocellis, L., Pryce, G., Baker, D., Guglielmotti, V., & Di Marzo, V. (2006) · Neuroscience · doi:10.1016/j.neuroscience.2006.02.074 · Cited by 491
TRPV4 calcium entry channel: a paradigm for gating diversity
Nilius, B., Vriens, J., Prenen, J., Droogmans, G., & Voets, T. (2004) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00365.2003 · Cited by 491
The Endocannabinoid System and Pain
Guindon, J., & Hohmann, A. (2009) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/187152709789824660 · Cited by 476
A TRP channel trio mediates acute noxious heat sensing
Vandewauw, I., De Clercq, K., Mulier, M., Held, K., Pinto, S., Van Ranst, N., Segal, A., Voet, T., Vennekens, R., Zimmermann, K., et al. (2018) · Nature · doi:10.1038/nature26137 · Cited by 470
Molecular Targets of the Phytocannabinoids: A Complex Picture
Morales, P., Hurst, D. P., & Reggio, P. H. (2017) · Progress in the Chemistry of Organic Natural Products · doi:10.1007/978-3-319-45541-9_4 · Cited by 454
Self-citationIannotti, F. A., Hill, C. L., Leo, A., Alhusaini, A., Soubrane, C., Mazzarella, E., Russo, E., Whalley, B. J., Di Marzo, V., & Stephens, G. J. (2014) · ACS Chemical Neuroscience · doi:10.1021/cn5000524 · Cited by 413
Qin, N., Neeper, M. P., Liu, Y., Hutchinson, T. L., Lubin, M. L., & Flores, C. M. (2008) · Journal of Neuroscience · doi:10.1523/jneurosci.0504-08.2008 · Cited by 396
TRP channels: Targets for the relief of pain
Levine, J. D., & Alessandri-Haber, N. (2007) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2007.01.008 · Cited by 363
De Petrocellis, L., Bisogno, T., Maccarrone, M., Davis, J. B., Finazzi-Agrò, A., & Di Marzo, V. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m008555200 · Cited by 355
Cannabinoid CB2 receptor ligand profiling reveals biased signalling and off-target activity
Soethoudt, M., Grether, U., Fingerle, J., Grim, T. W., Fezza, F., de Petrocellis, L., Ullmer, C., Rothenhäusler, B., Perret, C., van Gils, N., et al. (2017) · Nature Communications · doi:10.1038/ncomms13958 · Cited by 349
N-Oleoyldopamine, a Novel Endogenous Capsaicin-like Lipid That Produces Hyperalgesia
Chu, C. J., Huang, S. M., De Petrocellis, L., Bisogno, T., Ewing, S. A., Miller, J. D., Zipkin, R. E., Daddario, N., Appendino, G., Di Marzo, V., et al. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m211231200 · Cited by 345
De Petrocellis, L., Vellani, V., Schiano-Moriello, A., Marini, P., Magherini, P. C., Orlando, P., & Di Marzo, V. (2008) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.107.134809 · Cited by 336
De Petrocellis, L., Orlando, P., Moriello, A. S., Aviello, G., Stott, C., Izzo, A. A., & Di Marzo, V. (2012) · Acta Physiologica · doi:10.1111/j.1748-1716.2011.02338.x · Cited by 323
TRPV3 and TRPV4 Mediate Warmth-evoked Currents in Primary Mouse Keratinocytes
Chung, M.-K., Lee, H., Mizuno, A., Suzuki, M., & Caterina, M. J. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m401872200 · Cited by 316
Structure of the cold- and menthol-sensing ion channel TRPM8
Yin, Y., Wu, M., Zubcevic, L., Borschel, W. F., Lander, G. C., & Lee, S.-Y. (2018) · Science · doi:10.1126/science.aan4325 · Cited by 302
The thermo‐TRP ion channel family: properties and therapeutic implications
Vay, L., Gu, C., & McNaughton, P. A. (2012) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01601.x · Cited by 296
The cannabinoid system and pain
Woodhams, S. G., Chapman, V., Finn, D. P., Hohmann, A. G., & Neugebauer, V. (2017) · Neuropharmacology · doi:10.1016/j.neuropharm.2017.06.015 · Cited by 267
Hill, T. D. M., Cascio, M., Romano, B., Duncan, M., Pertwee, R. G., Williams, C. M., Whalley, B. J., & Hill, A. J. (2013) · British Journal of Pharmacology · doi:10.1111/bph.12321 · Cited by 187
What do we know about the transient receptor potential vanilloid 2 (TRPV 2) ion channel?
Perálvarez‐Marín, A., Doñate‐Macian, P., & Gaudet, R. (2013) · The FEBS Journal · doi:10.1111/febs.12302 · Cited by 184
Ahluwalia, J., Urban, L., Bevan, S., & Nagy, I. (2003) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2003.02703.x · Cited by 183
Romano, B., Borrelli, F., Fasolino, I., Capasso, R., Piscitelli, F., Cascio, M., Pertwee, R., Coppola, D., Vassallo, L., Orlando, P., et al. (2013) · British Journal of Pharmacology · doi:10.1111/bph.12120 · Cited by 179
An Update on Non-CB 1 , Non-CB 2 Cannabinoid Related G-Protein-Coupled Receptors
Morales, P., & Reggio, P. H. (2017) · Cannabis and Cannabinoid Research · doi:10.1089/can.2017.0036 · Cited by 168
Self-citationAnand, U., Otto, W. R., Sanchez-Herrera, D., Facer, P., Yiangou, Y., Korchev, Y., Birch, R., Benham, C., Bountra, C., Chessell, I. P., et al. (2008) · Pain · doi:10.1016/j.pain.2008.06.007 · Cited by 166 · cited 1×
“Interestingly, CB1 has been suggested to colocalize with TRP channels such as TRPV1 in sensory and brain neurons (Ahluwalia et al., 2003; Price et al., 2004; Cristino et al., 2006), while CB2 colocalizes with this channel in sensory neurons and osteoclasts (Anand et al., 2008; Rossi et al., 2009).”
BackgroundPrice, T. J., Patwardhan, A. M., Akopian, A. N., Hargreaves, K., & Flores, C. M. (2004) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0705711 · Cited by 165
PETROCELLIS, L. D., Starowicz, K., Moriello, A. S., Vivese, M., Orlando, P., & Marzo, V. D. (2007) · Experimental Cell Research · doi:10.1016/j.yexcr.2007.01.008 · Cited by 161
TRPV4 Agonists and Antagonists
Vincent, F., & Duncton, M. A. J. (2011) · Current Topics in Medicinal Chemistry · doi:10.2174/156802611796904861 · Cited by 160
Ambrosino, P., Soldovieri, M. V., Russo, C., & Taglialatela, M. (2012) · British Journal of Pharmacology · doi:10.1111/bph.12029 · Cited by 156
Rossi, F., Siniscalco, D., Luongo, L., PETROCELLIS, L. D., Bellini, G., Petrosino, S., Torella, M., Santoro, C., Nobili, B., Perrotta, S., et al. (2008) · Bone · doi:10.1016/j.bone.2008.10.056 · Cited by 155
Petrosino, S., Moriello, A. S., Cerrato, S., Fusco, M., Puigdemont, A., PETROCELLIS, L. D., & Marzo, V. D. (2015) · British Journal of Pharmacology · doi:10.1111/bph.13084 · Cited by 150
Cannabinoids Desensitize Capsaicin and Mustard Oil Responses in Sensory Neurons via TRPA1 Activation
Akopian, A. N., Ruparel, N. B., Patwardhan, A. M., & Hargreaves, K. (2008) · Journal of Neuroscience · doi:10.1523/jneurosci.1565-06.2008 · Cited by 142
Use of Capsaicin to Treat Pain: Mechanistic and Therapeutic Considerations
Chung, M., & Campbell, J. N. (2016) · Pharmaceuticals · doi:10.3390/ph9040066 · Cited by 138
TRP Channel Cannabinoid Receptors in Skin Sensation, Homeostasis, and Inflammation
Caterina, M. J. (2014) · ACS Chemical Neuroscience · doi:10.1021/cn5000919 · Cited by 135
Raboune, S., Stuart, J. M., Leishman, E., Takacs, S. M., Rhodes, B. P., Basnet, A., Jameyfield, E., McHugh, D., Widlanski, T. S., & Bradshaw, H. B. (2014) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2014.00195 · Cited by 123
Liedtke, W. (2005) · The Journal of Physiology · doi:10.1113/jphysiol.2005.088963 · Cited by 117
Lipids as regulators of the activity of transient receptor potential type V1 (TRPV1) channels
PETROCELLIS, L. D., & Marzo, V. D. (2005) · Life Sciences · doi:10.1016/j.lfs.2005.05.021 · Cited by 114
Actions and Regulation of Ionotropic Cannabinoid Receptors
PETROCELLIS, L. D., Nabissi, M., Santoni, G., & Ligresti, A. (2017) · Advances in pharmacology · doi:10.1016/bs.apha.2017.04.001 · Cited by 91
Winter, Z., Buhala, A., Ötvös, F., Jósvay, K., Vízler, C., Dombi, G., Szakonyi, G., & Oláh, Z. (2013) · Molecular Pain · doi:10.1186/1744-8069-9-30 · Cited by 89
Storozhuk, M., & Zholos, A. V. (2017) · Current Neuropharmacology · doi:10.2174/1570159x15666170424120802 · Cited by 83
Cannabinoid-based drugs targeting CB1 and TRPV1, the sympathetic nervous system, and arthritis
Lowin, T., & Straub, R. H. (2015) · Arthritis Research & Therapy · doi:10.1186/s13075-015-0743-x · Cited by 82
Towards a better understanding of the cannabinoid-related orphan receptors GPR3, GPR6, and GPR12
Morales, P., Isawi, I. H., & Reggio, P. H. (2018) · Drug Metabolism Reviews · doi:10.1080/03602532.2018.1428616 · Cited by 58
Self-citationPETROCELLIS, L. D., Moriello, A. S., Imperatore, R., Cristino, L., Starowicz, K., & Marzo, V. D. (2012) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2012.02122.x · Cited by 54
PETROCELLIS, L. D., Guida, F., Moriello, A. S., Chiaro, M. D., Piscitelli, F., de Novellis, V., Maione, S., & Marzo, V. D. (2011) · Pharmacological Research · doi:10.1016/j.phrs.2010.12.019 · Cited by 40
Ligand determinants of fatty acid activation of the pronociceptive ion channel TRPA1
Redmond, W. J., Gu, L., Camo, M., McIntyre, P., & Connor, M. A. (2014) · PeerJ · doi:10.7717/peerj.248 · Cited by 37
Cannabinoid receptors and TRPA1 on neuroprotection in a model of retinal ischemia
de Araújo, D. S. M., Miya-Coreixas, V. S., Pandolfo, P., & Calaza, K. D. C. (2016) · Experimental Eye Research · doi:10.1016/j.exer.2016.11.015 · Cited by 31
Luongo, L., Costa, B., D’Agostino, B., Guida, F., Comelli, F., Gatta, L., Matteis, M., Sullo, N., PETROCELLIS, L. D., de Novellis, V., et al. (2012) · Pharmacological Research · doi:10.1016/j.phrs.2012.05.005 · Cited by 24
Two to tango: GPCR oligomers and GPCR-TRP channel interactions in nociception
Yekkirala, A. S. (2013) · Life Sciences · doi:10.1016/j.lfs.2012.06.021 · Cited by 24
High-Resolution Views of TRPV1 and Their Implications for the TRP Channel Superfamily
Hellmich, U. A., & Gaudet, R. (2014) · Handbook of experimental pharmacology · doi:10.1007/978-3-319-05161-1_11 · Cited by 17
Small Molecule Agonists and Antagonists of TRPV4
Duncton, M. A. J. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-420024-1.00012-6 · Cited by 12
Cited by
Antioxidative and Anti-Inflammatory Properties of Cannabidiol
Atalay, S., Jarocka-Karpowicz, I., & Skrzydlewska, E. (2019) · Antioxidants · doi:10.3390/antiox9010021 · Cited by 818
Zhang, M., Ma, Y., Ye, X., Zhang, N., Pan, L., & Wang, B. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01464-x · Cited by 522
The Endocannabinoid System: A Potential Target for the Treatment of Various Diseases
Lowe, H., Toyang, N., Steele, B., Bryant, J., & Ngwa, W. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22179472 · Cited by 303
A microbiome-dependent gut–brain pathway regulates motivation for exercise
Dohnalová, L., Lundgren, P., Carty, J. R. E., Goldstein, N., Wenski, S. L., Nanudorn, P., Thiengmag, S., Huang, K.-P., Litichevskiy, L., Descamps, H. C., et al. (2022) · Nature · doi:10.1038/s41586-022-05525-z · Cited by 279
Goods and Bads of the Endocannabinoid System as a Therapeutic Target: Lessons Learned after 30 Years
Maccarrone, M., Di Marzo, V., Gertsch, J., Grether, U., Howlett, A. C., Hua, T., Makriyannis, A., Piomelli, D., Ueda, N., & van der Stelt, M. (2023) · Pharmacological Reviews · doi:10.1124/pharmrev.122.000600 · Cited by 183
Metadata
- Authors
- Muller, C., Morales, P., & Reggio, P. H.
- Venue
- Frontiers in Molecular Neuroscience
- Publisher
- Frontiers Media SA
- Published
- 2019-01-15
- Volume
- 11
- Pages
- 487-487
- ISSN
- 1662-5099 (ISSN-L)
- OpenAlex
- W2904621147
- Cited by
- 567
- References
- 61
- FWCI
- 39.03
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.